Published in Bioconjug Chem on October 01, 2014
Quantum Dot Surface Engineering: Toward Inert Fluorophores with Compact Size and Bright, Stable Emission. Coord Chem Rev (2016) 0.75
Highly sensitive detection of protein biomarkers via nuclear magnetic resonance biosensor with magnetically engineered nanoferrite particles. Int J Nanomedicine (2016) 0.75
Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov (2008) 12.72
Fcgamma receptors as regulators of immune responses. Nat Rev Immunol (2008) 11.34
IgG Fc receptors. Annu Rev Immunol (2001) 8.63
One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst (1977) 6.91
Fc receptor biology. Annu Rev Immunol (1997) 5.08
Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res (2003) 4.30
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res (2001) 4.19
Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer (2002) 3.75
Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol (2009) 3.05
A compendium of potential biomarkers of pancreatic cancer. PLoS Med (2009) 3.00
Roles of Fc receptors in autoimmunity. Nat Rev Immunol (2002) 2.96
Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas. Int J Cancer (1975) 2.78
Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol (2003) 2.63
The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer (2006) 2.61
A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch (2003) 2.53
Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics (2012) 2.35
Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res (2001) 2.24
Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol (2002) 2.22
Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis. Am J Clin Pathol (2005) 2.21
Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase. Int J Cancer (1977) 2.12
High-affinity adaptors for switchable recognition of histidine-tagged proteins. J Am Chem Soc (2005) 2.06
MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Mol Cancer Res (2007) 2.00
Human antibody-Fc receptor interactions illuminated by crystal structures. Nat Rev Immunol (2004) 1.91
Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Mol Cancer Ther (2008) 1.90
Multifunctional nanoparticles--properties and prospects for their use in human medicine. Trends Biotechnol (2008) 1.86
Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma. Am J Pathol (1998) 1.82
Biological applications of magnetic nanoparticles. Chem Soc Rev (2012) 1.76
Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology (2001) 1.75
Characterization of a new primary human pancreatic tumor line. Cancer Invest (1986) 1.67
Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett (2008) 1.62
Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J Clin Pathol (2004) 1.37
Chimeric IgG-binding receptors engineered from staphylococcal protein A and streptococcal protein G. J Biol Chem (1988) 1.33
The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma. Pancreas (2004) 1.31
Quantum dot imaging platform for single-cell molecular profiling. Nat Commun (2013) 1.29
Synthesis, encapsulation, purification and coupling of single quantum dots in phospholipid micelles for their use in cellular and in vivo imaging. Nat Protoc (2007) 1.29
Quantum dots in bioanalysis: a review of applications across various platforms for fluorescence spectroscopy and imaging. Appl Spectrosc (2013) 1.21
Oligohis-tags: mechanisms of binding to Ni2+-NTA surfaces. J Mol Recognit (2009) 1.19
Facile synthesis of multivalent nitrilotriacetic acid (NTA) and NTA conjugates for analytical and drug delivery applications. Bioconjug Chem (2006) 1.19
Definition of IgG- and albumin-binding regions of streptococcal protein G. J Biol Chem (1987) 1.11
MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms. Oncogene (2006) 1.06
Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer. Mol Imaging (2007) 1.04
Lipid-quantum dot bilayer vesicles enhance tumor cell uptake and retention in vitro and in vivo. ACS Nano (2008) 0.98
Antibody-protein A conjugated quantum dots for multiplexed imaging of surface receptors in living cells. Mol Biosyst (2010) 0.92
Heterogeneous expression of claudin-4 in human colorectal cancer: decreased claudin-4 expression at the invasive front correlates cancer invasion and metastasis. Pathobiology (2007) 0.89
One-step purification of monoclonal IgG antibodies from mouse ascites. An evaluation of different adsorption techniques using high performance liquid chromatography. J Immunol Methods (1988) 0.85
Affinity capturing for targeting proteins into micro and nanostructures. Anal Bioanal Chem (2009) 0.83
Quantum dots find their stride in single molecule tracking. Curr Opin Chem Biol (2011) 0.83
Quantitative molecular profiling of biomarkers for pancreatic cancer with functionalized quantum dots. Nanomedicine (2012) 0.81
Mucin genes (MUC2, MUC4, MUC5AC, and MUC6) detection in normal and pathological endometrial tissues. Int J Gynecol Pathol (2007) 0.81
Quantitative characterization of the lipid encapsulation of quantum dots for biomedical applications. Nanomedicine (2011) 0.79
Antibody-antigen binding constants determined in solution-phase with the threshold membrane-capture system: binding constants for anti-fluorescein, anti-saxitoxin, and anti-ricin antibodies. Anal Biochem (1994) 0.79
High throughput bioassays using nanoparticles. Comb Chem High Throughput Screen (2010) 0.77
The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nat Rev Cancer (2011) 3.42
A perinuclear actin cap regulates nuclear shape. Proc Natl Acad Sci U S A (2009) 3.12
Multifunctional nanorods for gene delivery. Nat Mater (2003) 2.09
Influence of solvent on the growth of ZnO nanoparticles. J Colloid Interface Sci (2003) 1.31
Programmed subcellular release for studying the dynamics of cell detachment. Nat Methods (2009) 1.15
The blood-brain barrier: an engineering perspective. Front Neuroeng (2013) 1.09
Kinetics of desorption of alkanethiolates on gold. Langmuir (2006) 0.98
Electrochemically programmed release of biomolecules and nanoparticles. Nano Lett (2006) 0.95
Single nanoporous gold nanowire sensors. J Phys Chem B (2006) 0.94
CuInSe/ZnS core/shell NIR quantum dots for biomedical imaging. Small (2011) 0.94
Quantifying electrochemical nucleation and growth of nanoscale clusters using real-time kinetic data. Nano Lett (2006) 0.93
FIB/TEM characterization of the composition and structure of core/shell Cu-Ni nanowires. Nano Lett (2008) 0.92
A membrane-translocating peptide penetrates into bilayers without significant bilayer perturbations. Biophys J (2013) 0.91
Characterization of antimicrobial peptide activity by electrochemical impedance spectroscopy. Biochim Biophys Acta (2008) 0.90
Orientation of a nanocylinder at a fluid interface. J Phys Chem B (2006) 0.89
Coarsening of metal oxide nanoparticles. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 0.89
A systematic in-vivo toxicity evaluation of nanophosphor particles via zebrafish models. Biomaterials (2013) 0.87
Effect of a polymer cushion on the electrical properties and stability of surface-supported lipid bilayers. Langmuir (2010) 0.87
The influence of electric field and confinement on cell motility. PLoS One (2013) 0.85
Electrical measurements of bilayer membranes formed by Langmuir-Blodgett deposition on single-crystal silicon. Langmuir (2007) 0.85
Interactions of membrane active peptides with planar supported bilayers: an impedance spectroscopy study. Langmuir (2012) 0.84
Highly efficient macromolecule-sized poration of lipid bilayers by a synthetically evolved peptide. J Am Chem Soc (2014) 0.84
Triggering cell detachment from patterned electrode arrays by programmed subcellular release. Nat Protoc (2010) 0.83
Interplay of RhoA and motility in the programmed spreading of daughter cells postmitosis. Biophys J (2010) 0.82
Microwave annealing effect for highly reliable biosensor: dual-gate ion-sensitive field-effect transistor using amorphous InGaZnO thin-film transistor. ACS Appl Mater Interfaces (2014) 0.82
Think modular: a simple apoferritin-based platform for the multifaceted detection of pancreatic cancer. ACS Nano (2013) 0.81
Nanoscale bacteriophage biosensors beyond phage display. Int J Nanomedicine (2013) 0.81
Quantitative molecular profiling of biomarkers for pancreatic cancer with functionalized quantum dots. Nanomedicine (2012) 0.81
Site-selective patterning using surfactant-based resists. J Am Chem Soc (2005) 0.81
Magnetic bead-quantum dot assay for detection of a biomarker for traumatic brain injury. Nanoscale (2015) 0.80
Quantitative characterization of the lipid encapsulation of quantum dots for biomedical applications. Nanomedicine (2011) 0.79
Electrochemical release of fluorescently labeled thiols from patterned gold surfaces. Langmuir (2010) 0.79
Harnessing immunomagnetic separation and quantum dot-based quantification capacities for the enumeration of absolute levels of biomarker. Nanotechnology (2013) 0.79
Surface-tethered protein switches. Chem Commun (Camb) (2011) 0.79
Tailoring Mg(x)Mn(1-x)Fe(2)O(4) superparamagnetic nanoferrites for magnetic fluid hyperthermia applications. ACS Appl Mater Interfaces (2014) 0.79
Impedance spectroscopy of bilayer membranes on single crystal silicon. Biointerphases (2008) 0.78
Bias-dependent admittance in hybrid bilayer membranes. Langmuir (2006) 0.78
Facile solvothermal preparation of monodisperse gold nanoparticles and their engineered assembly of ferritin-gold nanoclusters. Langmuir (2013) 0.78
Effect of modifying quantum dot surface charge on airway epithelial cell uptake in vitro. Nanotoxicology (2012) 0.77
Immunomagnetic nanoparticle-based assays for detection of biomarkers. Int J Nanomedicine (2013) 0.77
Electrically addressable, biologically relevant surface-supported bilayers. Langmuir (2010) 0.77
Electrochemical template synthesis of multisegment nanowires: fabrication and protein functionalization. Langmuir (2006) 0.77
Technology advancement for integrative stem cell analyses. Tissue Eng Part B Rev (2014) 0.77
Influence of applied potential on the impedance of alkanethiol SAMs. Langmuir (2007) 0.76
Real-time quantification of endothelial response to shear stress and vascular modulators. Integr Biol (Camb) (2017) 0.76
Overview of current standpoints in profiling of circulating tumor cells. Arch Pharm Res (2013) 0.75
Quantification of cardiovascular disease biomarkers via functionalized magnetic beads and on-demand detachable quantum dots. Nanoscale (2013) 0.75
Real-time imaging and quantitative analysis of doxorubicin transport in a perfusable microvessel platform. Integr Biol (Camb) (2016) 0.75
The solvothermal synthesis of magnetic iron oxide nanocrystals and the preparation of hybrid poly(L-lactide)-polyethyleneimine magnetic particles. Colloids Surf B Biointerfaces (2013) 0.75
Pilot study on effects of nanoparticle exposure on Crassostrea virginica hemocyte phagocytosis. Mar Pollut Bull (2012) 0.75
Influence of anion on the kinetics of copper island growth. Nanoscale (2010) 0.75
Kinetic Monte Carlo simulations of nucleation and growth in electrodeposition. J Phys Chem B (2005) 0.75
Anisotropic island growth: a new approach to thin film electrocrystallization. Langmuir (2008) 0.75
Kinetics of receptor directed assembly of multisegment nanowires. J Phys Chem B (2006) 0.75
Synthesis of ZnO nanoparticles in 2-propanol by reaction with water. J Phys Chem B (2005) 0.75
Influence of the reactant concentrations on the synthesis of ZnO nanoparticles. J Colloid Interface Sci (2005) 0.75